Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
A short telomere length predicts adverse clinical outcomes following revascularisation procedures independent of age, according to a finalist abstract at the Cardiovascular Ageing and Senescence Young Investigator Award yesterday.
It is now well established that telomeres, the caps protecting the ends of chromosomes, shorten with age. Several large studies have shown that telomere shortening contributes to mortality in many age-related diseases, and that mean telomere length predicts CHD.
In yesterday’s study Marios Margaritis and Charalambos Antoniades from the University of Oxford hypothesised that shortened telomeres could predict adverse events following revascularisation. They followed up 500 patients having PCI following STEMI and 648 CABG, with telomere length evaluated by PCR of whole blood.
Results showed patients with short relative telomere length were significantly more likely to experience CVD death than those with long relative telomere length (p<0.05), non-fatal acute coronary syndrome (p<0.05), all-cause mortality (P<0.05), and paroxysmal atrial fibrillation after CABG (p<0.01). ‘We believe telomere length measurement could be used to identify patients at greater risk following revascularisation and that such information could be incorporated into risk prediction models,’ said Antoniades.
Programme number 1834: Telomere length predicts clinical outcomes post revascularization procedures: its role as a novel biomarker of systemic oxidative stress and cardiovascular ageing.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved